NCT02332668
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02332668
Title A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Acronym MK-3475-051/KEYNOTE-051
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: child
Covered Countries USA | SWE | NLD | ITA | ISR | GBR | FRA | DEU | BRA

Facility Status City State Zip Country Details
Call for Information (Investigational Site 0019) RECRUITING Aurora Colorado 80045 United States Details
Call for Information (Investigational Site 0026) RECRUITING Boston Massachusetts 02445 United States Details
Call for Information (Investigational Site 0031) RECRUITING New York New York 10032 United States Details
Call for Information (Investigational Site 0070) RECRUITING Fargo North Dakota 58122 United States Details
Call for Information (Investigational Site 0032) RECRUITING Cincinnati Ohio 45229 United States Details
Call for Information (Investigational Site 0071) RECRUITING Sioux Falls South Dakota 57117 United States Details
Call for Information (Investigational Site 0054) RECRUITING Dallas Texas 75235 United States Details
MSD Brasil RECRUITING São Paulo Brazil Details
MSD France RECRUITING Paris France Details
MSD Sharp & Dohme GmbH RECRUITING München Germany Details
Merck Sharp & Dohme Co. Ltd. RECRUITING Hod HaSharon Israel Details
MSD Italia S.r.l. RECRUITING Rome Italy Details
Merck Sharp & Dohme BV RECRUITING Haarlem Netherlands Details
Merck Sharp & Dohme Lda. RECRUITING Paço de Arcos Portugal Details
MSD Korea LTD RECRUITING Seoul 4130 South Korea Details
MSD Sweden RECRUITING Stockholm Sweden Details
Merck Sharp & Dohme Ltd. RECRUITING London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field